NASDAQ:EQ

Equillium Stock Predictions

etoro logo Buy EQ
*Your capital is at risk
$3.11
+0.320 (+11.47%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

EQ Prediction Chart

EQ Predictions History

Latest community submissions for EQ.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 2, 2026 $1.48 -4.65% $1.53 V 96.59% 1
Jan 2, 2026 $1.50 -2.91% $1.53 V 98.36% 1
Jan 2, 2026 Bullish $1.53 X 0
Dec 30, 2025 $1.40 -5.01% $1.55 X 90.08% 0
Dec 30, 2025 $1.42 -3.13% $1.55 X 91.87% 0
Dec 30, 2025 Bullish $1.55 V 1
Apr 30, 2024 $1.71 +5.19% $1.49 X 84.92% 0
Apr 30, 2024 $1.68 +3.25% $1.49 X 87.05% 0
Apr 30, 2024 Bullish $1.49 X 0
Jun 5, 2023 $0.652 +3.56% $0.635 V 97.25% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for EQ with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT EQUILLIUM INC.
Equillium
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE